학술논문
Dose Reductions and Discontinuations with Chronic Lymphocytic Leukemia (CLL) Patients Receiving Ibrutinib in Community and Academic Settings
Document Type
Abstract
Author
Source
In Blood 5 November 2020 136 Supplement 1:12-13
Subject
Language
ISSN
0006-4971